Skip to content


Hysingla Er, Vantrela Er, Zohydro Er (hydrocodone) is a small molecule pharmaceutical. Hydrocodone was first approved as Hysingla Er on 2013-10-25. It is used to treat cough, obstructive lung diseases, and postoperative pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target kappa-type opioid receptor. Hydrocodone bitartrate and homatropine methylbromide's patents are valid until 2034-09-12 (FDA).
Trade Name Hysingla Er, Vantrela Er, Zohydro Er
Common Name Hydrocodone
Indication cough, obstructive lung diseases, postoperative pain
Drug Class
Get full access now